The Mandate
"I started Dual Sphere because senior expertise in HEOR should not require a client to navigate a 300-person firm to access it. After two decades working inside some of the largest organisations in this industry - building models, writing dossiers, advising on submissions - I know exactly where value is created in this work and where it isn't. At Dual Sphere, the person with the deepest relevant experience is involved in your project directly, from the first conversation to the final deliverable."
20 years · IQVIA · Parexel · TCS · Capita · ISPOR India President-Elect
Scientific Philosophy
Good HEOR is not about producing documents. It is about understanding what a specific payer body will accept, why, and how to structure the evidence to reach that outcome. That requires someone who has read the guidance, attended the conferences, and engaged with the scientific committees - not someone who has read about them.
Professional Roles
ISPOR India Chapter - President-Elect (ISPOR is the International Society for Pharmacoeconomics and Outcomes Research) - the primary global professional and scientific society for this field. (President-Elect is a peer-elected position.)
Therapeutic Areas
Geographic Expertise
Career Trajectory
Dual Sphere Consulting
Founded 2025. Operates from Singapore, UK and India with Global client engagements.
IQVIA
Senior consulting and leadership in HEOR, real-world evidence, and global market access.
TCS (Tata Consultancy Services)
HEOR and RWE delivery across global pharma clients.
Capita
Early career foundation in health economics and outcomes research.
Heron (Parexel)
Market access consulting and HTA submission support.
The Team
The Dual Sphere team brings together health economists, systematic reviewers, medical writers, and market access strategists. Every team member has life sciences or academic HEOR backgrounds - not general consulting backgrounds.

Associate Director
Dr Henna Khan
Systematic literature reviews, meta-analyses, and evidence synthesis. Specialisation in oncology and rare disease evidence packages.

Associate Director
Venkata Sharmila Uribandi
Medical communications and value dossier development. Experience in translating complex clinical and economic evidence for payer audiences.

Associate Director
Ravikishore
Real-world evidence study design and execution. Database analysis and retrospective cohort study methodology.

Senior Consultant
Dr Akanksha Verma
Health economic modelling and RWE strategy. Background in pharmacoeconomic model development and evidence synthesis for global HTA submissions.
Execution Team

Consultant
Dr Anjali V Joseph

Consultant
Abhilash

Senior Analyst
Dr. Saba Abidi

Analyst
Vaisshnavi Goel

Analyst
Dr Aishwarya Naruboina

Analyst
Dr Mounika Musalreddygari

Analyst
Mrs. Pratiksha Sumit Bulkunde
Leadership In Action
Working on a submission, a
model, or a strategy?
Let's talk
We take on a focused number of engagements at any time to ensure senior-level attention on every project.
Start a conversation







